Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alagille syndrome today

D Alagille1

  • 1Université Paris-Sud in Bicêtre, France.

Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|October 1, 1996
PubMed
Summary
This summary is machine-generated.

Alagille syndrome, a genetic disorder affecting bile ducts, presents with distinct facial features, chronic cholestasis, and other anomalies. Management includes nutritional support and, in severe cases, liver transplantation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

History of pediatric liver transplantation in Europe.

Acta gastro-enterologica Belgica·2004
Same author

Synthesis and in vitro cytotoxic evaluation of N-substituted benzo[5,6]cycloheptal[b]indoles.

Chemical & pharmaceutical bulletin·2001
Same author

Deleted chromosome 20 from a patient with Alagille syndrome isolated in a cell hybrid through leucine transport selection: study of three candidate genes.

Mammalian genome : official journal of the International Mammalian Genome Society·1994
Same author

[Renal involvement in the Alagille syndrome].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·1994
Same author

[Jean-François Borel: discoverer of cyclosporin].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·1994
Same author

[Hepatitis C in children].

Archives francaises de pediatrie·1993
Same journal

Newsletter Spring 2026: Clinician Investigator Trainee Association of Canada (CITAC).

Clinical and investigative medicine. Medecine clinique et experimentale·2026
Same journal

A study of suicide risk and prognostic characteristics in patients with osteosarcoma.

Clinical and investigative medicine. Medecine clinique et experimentale·2026
Same journal

The expression and mechanism of action of MicroRNA-210 in preeclampsia.

Clinical and investigative medicine. Medecine clinique et experimentale·2026
Same journal

Risk assessment of intra-operative hemodynamic instability in patients with pheochromocytoma.

Clinical and investigative medicine. Medecine clinique et experimentale·2026
Same journal

Development and validation of a deep vein thrombosis risk nomogram for post-operative complications in prostate cancer patients.

Clinical and investigative medicine. Medecine clinique et experimentale·2026
Same journal

Analysis of the impact of SARS-CoV-2 infection on immune function and metabolic changes in college students.

Clinical and investigative medicine. Medecine clinique et experimentale·2026
See all related articles

Area of Science:

  • Genetics
  • Pediatrics
  • Hepatology

Background:

  • Alagille syndrome is a genetic disorder characterized by a paucity of interlobular bile ducts.
  • It typically manifests with five key features: characteristic facies, chronic cholestasis, posterior embryotoxon, vertebral defects, and cardiovascular malformations.
  • The syndrome exists in complete and incomplete forms, with varying numbers of these defining characteristics.

Purpose of the Study:

  • To describe the clinical characteristics, genetic transmission, and management of Alagille syndrome.
  • To highlight the spectrum of clinical presentations and associated anomalies.
  • To outline current therapeutic strategies, including nutritional support and liver transplantation.

Main Methods:

  • Clinical case review and analysis of genetic transmission patterns.

Related Experiment Videos

  • Compilation of data on diagnostic criteria and associated symptoms.
  • Review of treatment outcomes for nutritional management and liver transplantation.

    • Main Results:

    • Alagille syndrome is an autosomal dominant disorder with variable penetrance.
    • Common features include facial dysmorphia, cholestasis, ocular anomalies, skeletal defects, and cardiac issues.
    • Less frequent manifestations involve growth and developmental delays, renal, bone, and voice abnormalities.

    Conclusions:

    • Alagille syndrome requires a multidisciplinary approach for diagnosis and management.
    • Nutritional supplementation with medium-chain triglycerides, essential fatty acids, and fat-soluble vitamins is a cornerstone of therapy.
    • Liver transplantation offers a viable option for patients with end-stage liver disease or severe complications.